Details of the Drug Reposition

General Information of This Drug (ID: DMKLMV9)

• Drug Name: IMA201 (DMKLMV9)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Squamous cell carcinoma	DISQVIFL	2B60-2D01	Phase 1	[1]
Non-small-cell lung cancer	DIS5Y6R9	2C25.Y	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)